Working Together to Understand, Protect and Restore Vision
1st Annual Sandra Lemke Trout Lecture Saturday, September 23rd, 2023; Lawrence University Music-Drama Center, Stansbury Theater Guest Speaker: Kapil Bharti (Director of the National Eye Institute) Age-Related Macular Degeneration: Clinical Trials, Stem Cells, and other Therapies
TUESDAY, SEPTEMBER 12, 2023 – 3571 WIMR II TUESDAY, OCTOBER 10, 2023 – 1360 BIOTECH TUESDAY, NOVEMBER 14, 2023 – 3571 WIMR II TUESDAY, DECEMBER 12, 2023 – 1360 BIOTECH
Computational tool helps uncover gene networks of cell fate A recently published study from the Wisconsin Institute of Discovery (WID), titled Inference of cell type-specific gene regulatory networks on cell lineages from single cell omic datasets integrates both computational and biological sciences by using machine learning to better understand the driving forces of cellular identity. …
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy We are pleased to announce that a new study, with contributions by several MERI members, has just been published in The Journal of Clinical Investigation! The paper, entitled ‘Nonviral base editing of KCNJ13 mutation preserves vision in a model of …
Emerging technologies at UW–Madison Get Boost from State Funds Emerging technologies developed at UW–Madison will receive funding assistance as the result of an on-campus grant program administered by UW–Madison’s Discovery to Product (D2P) and a matching grant of $300,0000 from the Wisconsin Economic Development Corporation (WEDC). One project that is being funded by these programs …
Using several innovative delivery methods, the new consortium – including researchers Krishanu Saha, Sarah Gong, David Gamm, Bikash Pattnaik and T. Michael Nork – will move ahead with gene editing techniques to treat two rare blinding diseases, Best disease and Leber congentital amaurosis (LCA). Read more.
Our Spring 2023 newsletter reviews the extraordinary career of Dr. Alice McPherson; announces the new Trout AMD Project; and highlights a new $30 million NIH grant to MERI members to advance gene editing therapies for two devastating eye diseases.